Consumer Protection · The Ledger
7 red flags when choosing a peptide provider
We've scored eight providers on the same rubric. These are the patterns that separate the ones we'd send a family member to from the ones we wouldn't.
We've now scored eight providers on the same rubric. These are the patterns that separate the ones we'd send a family member to from the ones we wouldn't.
Red flag 1
They won't name the pharmacy. If a provider won't tell you which compounding pharmacy fills your prescription — before you order — that's the single strongest red flag in this category. Legitimate providers answer immediately. The pharmacy name should also appear on your label when it arrives.Red flag 2
The advertised price isn't the refill price. A $179 headline that becomes $299 on refill isn't a discount, it's a hook. Always calculate your six-month total. Providers using this structure aren't necessarily bad — but they're counting on you not doing the math.Red flag 3
They charge more at higher doses. GLP-1s titrate up over months. A provider that raises your price at each dose tier is charging you more for an identical service. Flat-rate providers exist; there's no reason to accept a surcharge.Red flag 4
Multi-month plans bill upfront and won't refund. Prepaid plans that take $1,482–$2,364 at checkout — sometimes before a clinician has confirmed you're eligible — and are non-refundable put all the risk on you. Read the cancellation policy before selecting anything longer than month-to-month.Red flag 5
No labs, no questions, instant approval. Speed is a feature until it isn't. A provider that will prescribe a GLP-1 with zero bloodwork and a five-minute questionnaire is optimizing for conversion, not for you. Get baseline labs regardless.Red flag 6
Marketing claims equivalence to the brand drug. 'Same as Wegovy', 'proven results', 'FDA-approved ingredients' framed to imply the product is FDA-approved — this is exactly the language that drew 80+ FDA warning letters since 2025. It's a sign of a compliance-loose operator. See the tracker.Red flag 7
They'll sell you retatrutide. Retatrutide is an investigational drug that cannot legally be compounded at all. Any provider or vendor offering it for human use is operating outside the rules. This is a bright line, and crossing it tells you everything about the rest of their compliance posture.The inverse checklist
A provider worth using will: name its pharmacy before you order, publish or provide batch testing, charge
one predictable price regardless of dose, let you cancel without a fight, and tell you plainly that
compounded medication is not FDA-approved. Our rankings score exactly these
things.The one that surprises people
None of these red flags are about the medication. Compounded semaglutide from a good 503A pharmacy and compounded semaglutide from a bad one contain the same intended molecule. Nearly all the risk you can actually control sits in the pharmacy sourcing and the billing structure — which is why those two axes carry 45% of our score combined.
FAQ
What's the biggest red flag in a peptide provider?
Refusing to name the compounding pharmacy that fills your prescription. Legitimate providers answer that question immediately and print the pharmacy name on your label. If they won't, you have no way to verify what's in the vial.
Is a provider that doesn't require bloodwork unsafe?
Not automatically, but it's a clinical shortcut. Only two of the eight providers we've reviewed require labs before prescribing. If yours doesn't, get a baseline panel independently — it costs $95–$500 and is the cheapest risk reduction available.
Should I avoid providers offering retatrutide?
Yes. Retatrutide is investigational and cannot legally be compounded under any circumstances. A provider selling it for human use is operating outside the rules, which tells you what to expect from the rest of their compliance posture.
Medical disclaimer: Veritide is an independent consumer-research publication, not a healthcare provider or pharmacy. This page is informational and is not medical advice. Compounded medications are not FDA-approved as finished products. Always consult a licensed clinician before starting any peptide or GLP-1 therapy.